A detailed history of Bill Few Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Bill Few Associates, Inc. holds 86,763 shares of PFE stock, worth $2.26 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
86,763
Previous 83,832 3.5%
Holding current value
$2.26 Million
Previous $2.35 Million 7.04%
% of portfolio
0.9%
Previous 0.91%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $81,188 - $92,004
2,931 Added 3.5%
86,763 $2.51 Million
Q2 2024

Jul 16, 2024

BUY
$25.26 - $29.6 $30,918 - $36,230
1,224 Added 1.48%
83,832 $2.35 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $66,563 - $76,435
2,571 Added 3.21%
82,608 $2.29 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $20,459 - $26,575
-783 Reduced 0.97%
80,037 $2.3 Million
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $11,809 - $13,803
368 Added 0.46%
80,820 $2.68 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $80,367 - $92,982
2,225 Added 2.84%
80,452 $2.95 Million
Q1 2023

Apr 17, 2023

BUY
$39.39 - $51.28 $76,101 - $99,072
1,932 Added 2.53%
78,227 $3.19 Million
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $92,309 - $120,499
2,211 Added 2.98%
76,295 $0
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $8,883 - $10,844
203 Added 0.27%
74,084 $3.24 Million
Q2 2022

Jul 26, 2022

SELL
$46.53 - $55.17 $69,143 - $81,982
-1,486 Reduced 1.97%
73,881 $3.87 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $49,364 - $61,168
1,079 Added 1.45%
75,367 $3.9 Million
Q4 2021

Mar 04, 2022

BUY
$41.32 - $61.25 $3.07 Million - $4.55 Million
74,288 New
74,288 $4.39 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.